Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its first quarter 2020 financial and operating results on Tuesday May 12, 2020 before the market opens. The company will host a conference call on Tuesday, May 12, 2020 at 8:30 a.m. Eastern Time.

To access the call live, please dial 416-406-0743 or 1-800-898-3989 and use access code 8842272#. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Tuesday, May 19, 2020 by dialing 905-694-9451 or 1-800-408-3053, using access code: 5893931#.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Acerus’ shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.

Acerus Pharmaceuticals Corporation Robert Motz Chief Financial Officer rmotz@aceruspharma.com (905) 817-8288

Acerus Pharmaceuticals (TSX:ASP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Acerus Pharmaceuticals Charts.
Acerus Pharmaceuticals (TSX:ASP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Acerus Pharmaceuticals Charts.